BRN insider filing: Director grant boosts Kenneth Grossman stake to 167,595

Rhea-AI Filing Summary

Kenneth S. Grossman, a director of Barnwell Industries, Inc. (BRN), was granted 65,000 shares of common stock on 09/29/2025. After the award, he beneficially owned 167,595 shares. The Form 4 indicates the award is a non-employee director grant approved by the board and reported by an attorney-in-fact signing on behalf of Mr. Grossman on 10/01/2025. The filing is a single-person Form 4 and does not disclose cash consideration or an exercise price because it records a direct stock award rather than a derivative transaction.

Positive

• Significant director ownership retained with 167,595 shares after the grant
• Board-approved equity award aligns a director’s interests with shareholders

Negative

• Potential dilution from a 65,000-share award if issued from authorized shares
• No cash consideration disclosed, increasing outstanding common stock without offsetting cash inflow

Insights

Corporate Governance Analyst

Director compensation granted: 65,000 shares increases insider alignment.

The award of 65,000 common shares to a non-employee director strengthens owner alignment without creating new derivative exposure; the filing shows the shares were granted on 09/29/2025 and increased beneficial ownership to 167,595 shares.

Dependence on board-approved grants means future dilution and compensation expense are possible; monitor upcoming proxy disclosures for the director compensation policy and share‑reserve details over the next 12 months.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GROSSMAN KENNETH S

(Last) (First) (Middle)

C/O BARNWELL INDUSTRIES, INC.

1100 ALAKEA STREET, SUITE 500

(Street)

HONOLULU HI 96813

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BARNWELL INDUSTRIES INC [ BRN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/29/2025		A		65,000	A	(1)	167,595	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a common stock award to a non-employee director made pursuant to a grant by the Board of Directors of Barnwell Industries, Inc. on September 29, 2025.

	/s/ Alexander C. Kinzler Attorney-in-fact for Kenneth S. Grossman	10/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Kenneth S. Grossman report on Form 4 for BRN?

The Form 4 reports a 65,000-share common stock award to Kenneth S. Grossman on 09/29/2025.

How many BRN shares does Kenneth S. Grossman beneficially own after the transaction?

He beneficially owns 167,595 shares following the reported award.

Was the award described as compensation for a director role or as an option?

The filing states it was a common stock award to a non-employee director, not a derivative or option.

Who signed the Form 4 filing for Kenneth S. Grossman?

The Form 4 was signed by Alexander C. Kinzler as attorney-in-fact on 10/01/2025.

Does the Form 4 disclose any cash received or prices for the shares?

No price or cash consideration is disclosed; the entry records the award as a grant rather than a purchase.